EFM
SAGE

E Fund Management’s Sage Therapeutics SAGE Stock Holding History

E Fund Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,544
Closed -$348K – 369
2024
Q1 		$348K Buy
18,544
+2,062
+13% +$47.6K 0.02% 254
2023
Q4 		$357K Sell
16,482
-4,678
-22% -$92.7K 0.02% 209
2023
Q3 		$435K Buy
21,160
+13,703
+184% +$396K 0.03% 147
2023
Q2 		$351K Sell
7,457
-1,955
-21% -$97.3K 0.03% 198
2023
Q1 		$395K Buy
9,412
+824
+10% +$35.4K 0.03% 170
2022
Q4 		$328K Sell
8,588
-2,753
-24% -$105K 0.03% 215
2022
Q3 		$444K Buy
11,341
+446
+4% +$17.2K 0.04% 153
2022
Q2 		$352K Buy
10,895
+2,261
+26% +$75.8K 0.03% 208
2022
Q1 		$286K Buy
+8,634
New +$325K 0.01% 211

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return